CompletedNot Applicable

Emotional Freedom Technique

Turkey (Türkiye)62 participantsStarted 2024-03-01

Plain-language summary

This study was conducted as a randomized controlled trial to examine the effect of the Emotional Freedom Technique on preoperative anxiety and postpartum depression in high-risk pregnant women who had decided to undergo planned cesarean delivery. Data were collected from women diagnosed with high-risk pregnancy who had made the decision for planned cesarean delivery in the last trimester of pregnancy. In the Emotional Freedom Technique group, the technique was applied during the preoperative period, while the standard care group received only standard care. The study was completed with 30 women in the Emotional Freedom Technique group and 32 women in the standard care group. The "Pregnant Introductory Information Form," the "State-Trait Anxiety Inventory," and the "Edinburgh Postnatal Depression Scale" were used as data collection tools. Pre-test and post-test applications of the scales were performed, and on the 21st day postpartum, the Edinburgh Postnatal Depression Scale was administered. For data analysis, descriptive statistics, independent samples t-test, paired samples t-test, ANOVA, and Pearson correlation analyses were used.

Who can participate

Age range

18 Years – 45 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Participants meeting the following criteria will be included in the study: Identified as at-risk pregnancies according to the Ministry of Health Risk Assessment Form, Able to speak and understand Turkish, Aged between 18 and 45 years, Have a planned cesarean delivery decision, Have a gestational age of 36 weeks or more, Have a State Anxiety Inventory (STAI-State) mean score of 37 or higher, Voluntarily agree to participate in the study. Exclusion Criteria Participants meeting any of the following criteria will be excluded from the study: Pregnant women evaluated between March 1, 2024 and September 30, 2024 at Ankara Etlik City Hospital, Perinatology Clinic, who decline voluntary participation, Pregnant women classified as low-risk according to the Ministry of Health Risk Assessment Form, Younger than 18 years or older than 45 years, Those who undergo vaginal delivery, Pregnant women with a gestational age of 35 weeks or less, Those with a State Anxiety Inventory (STAI-State) mean score of 36 or lower, Pregnant women with any psychiatric disorder or diagnosis, Those unable to speak or understand Turkish, Participants who withdraw from the study at any stage at their own request.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

State Anxiety Scale mean score

Timeframe: Before intervention (baseline) and immediately after intervention (post-test)

Trial details

NCT IDNCT07436832

SponsorMersin University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-30

View on ClinicalTrials.gov More High Risk Pregnancy trials